Nexalin Technology (NASDAQ:NXL) is a company that specializes in developing advanced medical devices designed to address mental health and neuropsychiatric disorders without the use of pharmaceuticals. At the heart of its innovation is a non-invasive therapy technology, which aims at treating anxiety, depression, and insomnia through transcranial electrical stimulation. With a commitment to improving the standard of mental health care, Nexalin continues to invest in research and development to expand its product portfolio and reach. The company's objective is to offer effective, drug-free solutions for mental health conditions, making treatment accessible and reducing the stigma associated with traditional psychiatric medications.